Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia

Abstract Bioengineered probiotics enable new opportunities to improve colorectal cancer (CRC) screening, prevention and treatment. Here, first, we demonstrate selective colonization of colorectal adenomas after oral delivery of probiotic E. coli Nissle 1917 (EcN) to a genetically-engineered murine m...

Full description

Bibliographic Details
Main Authors: Candice R. Gurbatri, Georgette A. Radford, Laura Vrbanac, Jongwon Im, Elaine M. Thomas, Courtney Coker, Samuel R. Taylor, YoungUk Jang, Ayelet Sivan, Kyu Rhee, Anas A. Saleh, Tiffany Chien, Fereshteh Zandkarimi, Ioana Lia, Tamsin R. M. Lannagan, Tongtong Wang, Josephine A. Wright, Hiroki Kobayashi, Jia Q. Ng, Matt Lawrence, Tarik Sammour, Michelle Thomas, Mark Lewis, Lito Papanicolas, Joanne Perry, Tracy Fitzsimmons, Patricia Kaazan, Amanda Lim, Alexandra M. Stavropoulos, Dion A. Gouskos, Julie Marker, Cheri Ostroff, Geraint Rogers, Nicholas Arpaia, Daniel L. Worthley, Susan L. Woods, Tal Danino
Format: Article
Language:English
Published: Nature Portfolio 2024-01-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-024-44776-4
_version_ 1827377170472763392
author Candice R. Gurbatri
Georgette A. Radford
Laura Vrbanac
Jongwon Im
Elaine M. Thomas
Courtney Coker
Samuel R. Taylor
YoungUk Jang
Ayelet Sivan
Kyu Rhee
Anas A. Saleh
Tiffany Chien
Fereshteh Zandkarimi
Ioana Lia
Tamsin R. M. Lannagan
Tongtong Wang
Josephine A. Wright
Hiroki Kobayashi
Jia Q. Ng
Matt Lawrence
Tarik Sammour
Michelle Thomas
Mark Lewis
Lito Papanicolas
Joanne Perry
Tracy Fitzsimmons
Patricia Kaazan
Amanda Lim
Alexandra M. Stavropoulos
Dion A. Gouskos
Julie Marker
Cheri Ostroff
Geraint Rogers
Nicholas Arpaia
Daniel L. Worthley
Susan L. Woods
Tal Danino
author_facet Candice R. Gurbatri
Georgette A. Radford
Laura Vrbanac
Jongwon Im
Elaine M. Thomas
Courtney Coker
Samuel R. Taylor
YoungUk Jang
Ayelet Sivan
Kyu Rhee
Anas A. Saleh
Tiffany Chien
Fereshteh Zandkarimi
Ioana Lia
Tamsin R. M. Lannagan
Tongtong Wang
Josephine A. Wright
Hiroki Kobayashi
Jia Q. Ng
Matt Lawrence
Tarik Sammour
Michelle Thomas
Mark Lewis
Lito Papanicolas
Joanne Perry
Tracy Fitzsimmons
Patricia Kaazan
Amanda Lim
Alexandra M. Stavropoulos
Dion A. Gouskos
Julie Marker
Cheri Ostroff
Geraint Rogers
Nicholas Arpaia
Daniel L. Worthley
Susan L. Woods
Tal Danino
author_sort Candice R. Gurbatri
collection DOAJ
description Abstract Bioengineered probiotics enable new opportunities to improve colorectal cancer (CRC) screening, prevention and treatment. Here, first, we demonstrate selective colonization of colorectal adenomas after oral delivery of probiotic E. coli Nissle 1917 (EcN) to a genetically-engineered murine model of CRC predisposition and orthotopic models of CRC. We next undertake an interventional, double-blind, dual-centre, prospective clinical trial, in which CRC patients take either placebo or EcN for two weeks prior to resection of neoplastic and adjacent normal colorectal tissue (ACTRN12619000210178). We detect enrichment of EcN in tumor samples over normal tissue from probiotic-treated patients (primary outcome of the trial). Next, we develop early CRC intervention strategies. To detect lesions, we engineer EcN to produce a small molecule, salicylate. Oral delivery of this strain results in increased levels of salicylate in the urine of adenoma-bearing mice, in comparison to healthy controls. To assess therapeutic potential, we engineer EcN to locally release a cytokine, GM-CSF, and blocking nanobodies against PD-L1 and CTLA-4 at the neoplastic site, and demonstrate that oral delivery of this strain reduces adenoma burden by ~50%. Together, these results support the use of EcN as an orally-deliverable platform to detect disease and treat CRC through the production of screening and therapeutic molecules.
first_indexed 2024-03-08T12:36:08Z
format Article
id doaj.art-16a3783ebc994816bc3440bb05df9c6f
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-03-08T12:36:08Z
publishDate 2024-01-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-16a3783ebc994816bc3440bb05df9c6f2024-01-21T12:27:29ZengNature PortfolioNature Communications2041-17232024-01-0115111310.1038/s41467-024-44776-4Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasiaCandice R. Gurbatri0Georgette A. Radford1Laura Vrbanac2Jongwon Im3Elaine M. Thomas4Courtney Coker5Samuel R. Taylor6YoungUk Jang7Ayelet Sivan8Kyu Rhee9Anas A. Saleh10Tiffany Chien11Fereshteh Zandkarimi12Ioana Lia13Tamsin R. M. Lannagan14Tongtong Wang15Josephine A. Wright16Hiroki Kobayashi17Jia Q. Ng18Matt Lawrence19Tarik Sammour20Michelle Thomas21Mark Lewis22Lito Papanicolas23Joanne Perry24Tracy Fitzsimmons25Patricia Kaazan26Amanda Lim27Alexandra M. Stavropoulos28Dion A. Gouskos29Julie Marker30Cheri Ostroff31Geraint Rogers32Nicholas Arpaia33Daniel L. Worthley34Susan L. Woods35Tal Danino36Department of Biomedical Engineering, Columbia UniversityAdelaide Medical School, University of AdelaideAdelaide Medical School, University of AdelaideDepartment of Biomedical Engineering, Columbia UniversityAdelaide Medical School, University of AdelaideDepartment of Biomedical Engineering, Columbia UniversityWeill Cornell-Rockefeller-Sloan Kettering Tri-Institutional MD-PhD programDepartment of Biomedical Engineering, Columbia UniversityDepartment of Biomedical Engineering, Columbia UniversityDivision of Infectious Diseases, Weill Department of Medicine, Weill Cornell MedicineDivision of Infectious Diseases, Weill Department of Medicine, Weill Cornell MedicineDepartment of Biomedical Engineering, Columbia UniversityDepartment of Chemistry, Columbia UniversityDepartment of Biomedical Engineering, Columbia UniversityAdelaide Medical School, University of AdelaideAdelaide Medical School, University of AdelaideSouth Australian Health and Medical Research Institute (SAHMRI)Adelaide Medical School, University of AdelaideAdelaide Medical School, University of AdelaideColorectal Unit, Department of Surgery, Royal Adelaide HospitalAdelaide Medical School, University of AdelaideColorectal Unit, Department of Surgery, Royal Adelaide HospitalColorectal Unit, Department of Surgery, Royal Adelaide HospitalSouth Australian Health and Medical Research Institute (SAHMRI)Colorectal Unit, Department of Surgery, Royal Adelaide HospitalColorectal Unit, Department of Surgery, Royal Adelaide HospitalAdelaide Medical School, University of AdelaideAdelaide Medical School, University of AdelaideAdelaide Medical School, University of AdelaideAdelaide Medical School, University of AdelaideCancer Voices SAUniversity of South AustraliaSouth Australian Health and Medical Research Institute (SAHMRI)Department of Microbiology & Immunology, Vagelos College of Physicians and Surgeons of Columbia UniversitySouth Australian Health and Medical Research Institute (SAHMRI)Adelaide Medical School, University of AdelaideDepartment of Biomedical Engineering, Columbia UniversityAbstract Bioengineered probiotics enable new opportunities to improve colorectal cancer (CRC) screening, prevention and treatment. Here, first, we demonstrate selective colonization of colorectal adenomas after oral delivery of probiotic E. coli Nissle 1917 (EcN) to a genetically-engineered murine model of CRC predisposition and orthotopic models of CRC. We next undertake an interventional, double-blind, dual-centre, prospective clinical trial, in which CRC patients take either placebo or EcN for two weeks prior to resection of neoplastic and adjacent normal colorectal tissue (ACTRN12619000210178). We detect enrichment of EcN in tumor samples over normal tissue from probiotic-treated patients (primary outcome of the trial). Next, we develop early CRC intervention strategies. To detect lesions, we engineer EcN to produce a small molecule, salicylate. Oral delivery of this strain results in increased levels of salicylate in the urine of adenoma-bearing mice, in comparison to healthy controls. To assess therapeutic potential, we engineer EcN to locally release a cytokine, GM-CSF, and blocking nanobodies against PD-L1 and CTLA-4 at the neoplastic site, and demonstrate that oral delivery of this strain reduces adenoma burden by ~50%. Together, these results support the use of EcN as an orally-deliverable platform to detect disease and treat CRC through the production of screening and therapeutic molecules.https://doi.org/10.1038/s41467-024-44776-4
spellingShingle Candice R. Gurbatri
Georgette A. Radford
Laura Vrbanac
Jongwon Im
Elaine M. Thomas
Courtney Coker
Samuel R. Taylor
YoungUk Jang
Ayelet Sivan
Kyu Rhee
Anas A. Saleh
Tiffany Chien
Fereshteh Zandkarimi
Ioana Lia
Tamsin R. M. Lannagan
Tongtong Wang
Josephine A. Wright
Hiroki Kobayashi
Jia Q. Ng
Matt Lawrence
Tarik Sammour
Michelle Thomas
Mark Lewis
Lito Papanicolas
Joanne Perry
Tracy Fitzsimmons
Patricia Kaazan
Amanda Lim
Alexandra M. Stavropoulos
Dion A. Gouskos
Julie Marker
Cheri Ostroff
Geraint Rogers
Nicholas Arpaia
Daniel L. Worthley
Susan L. Woods
Tal Danino
Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia
Nature Communications
title Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia
title_full Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia
title_fullStr Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia
title_full_unstemmed Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia
title_short Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia
title_sort engineering tumor colonizing e coli nissle 1917 for detection and treatment of colorectal neoplasia
url https://doi.org/10.1038/s41467-024-44776-4
work_keys_str_mv AT candicergurbatri engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT georgettearadford engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT lauravrbanac engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT jongwonim engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT elainemthomas engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT courtneycoker engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT samuelrtaylor engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT youngukjang engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT ayeletsivan engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT kyurhee engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT anasasaleh engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT tiffanychien engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT fereshtehzandkarimi engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT ioanalia engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT tamsinrmlannagan engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT tongtongwang engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT josephineawright engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT hirokikobayashi engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT jiaqng engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT mattlawrence engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT tariksammour engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT michellethomas engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT marklewis engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT litopapanicolas engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT joanneperry engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT tracyfitzsimmons engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT patriciakaazan engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT amandalim engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT alexandramstavropoulos engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT dionagouskos engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT juliemarker engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT cheriostroff engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT geraintrogers engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT nicholasarpaia engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT daniellworthley engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT susanlwoods engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia
AT taldanino engineeringtumorcolonizingecolinissle1917fordetectionandtreatmentofcolorectalneoplasia